Abstract:
The present invention provides compounds of formula (I) which are prodrugs of inhibitors of cathepsin S and as such are useful in the prevention and treatment of cathepsin S dependent diseases and conditions including, but not limited to, chronic obstructive pulmonary disease (COPD) and pain.
Abstract:
The invention relates to medicinally used substances which specifically inhibit peptidases splitting ala-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic composition containing such a substance for preventing and treating diseases, especially diseases with an overshooting immune response (autoimmune diseases, allergies, and transplant rejections), other chronic inflammatory diseases, neuronal diseases, brain damages, skin diseases (acne and psoriasis, among others), tumor diseases, and special viral infections (including SARS).
Abstract:
Alkenyldiarylmethane (ADAM) compounds have been found effective as anti-HIV agents. Novel ADAM compounds, their pharmaceutical formulations and a method of using same to treat viral infections are described.
Abstract:
The instant invention provides intermediates and processes for the preparation of compounds of formula (IV), wherein n is 0, 1, or 2; R is hydrogen or C1-C4 alkyl; X is hydrogen, cyano, 4-hydroxybenzoyl, 4-halobenzoyl, or 4-(C1-C4 alkoxy)benzoyl; Y is NR R , 4-hydroxyphenyl, or 4-(C1-C4 alkoxy)phenyl; and R and R are independently hydrogen or C1-C4 alkyl.
Abstract translation:本发明提供制备式(IV)化合物的中间体和方法,其中n为0,1或2; R是氢或C 1 -C 4烷基; X 1是氢,氰基,4-羟基苯甲酰基,4-卤代苯甲酰基或4-(C 1 -C 4烷氧基)苯甲酰基; Y是NR 4 R 5,4-羟基苯基或4-(C 1 -C 4烷氧基)苯基; R 4和R 5独立地是氢或C 1 -C 4烷基。
Abstract:
The invention concerns novel metal chelating compounds, and radiometal, e.g. technetium-99m complexes thereof. The compounds can be used to radiolabel small biologically active species with minimal effect on their biodistribution and activity. The compounds have formula (a) or (b), Z is (CR2)n or (CR)n, where n is 2 or 3, X a ligand comprising S, N or O, each R is H or C1-C20 substituted or unsubstituted hydrocarbon group, provided that 1-3 CR2 groups represent a CO (amide) moiety, and provided that one to three R may each comprise a targeting group and/or a protein reactive functionality.
Abstract:
The compounds of formula (I) in which L represents a radical of formula (a) or (b), and A1, B1 or A2 and B2 are defined as in claim 1, can be used as herbicides for combating pest plants or as plant growth regulators. The compounds can be produced according to the methods of claim 12.
Abstract:
The invention relates to novel phenyl-substituted 2-enamino-keto nitriles of formula (I), wherein Ar, X, Z, Y and K have the meanings as cited in the description. The invention also relates to several methods for producing said phenyl-substituted 2-enamino-keto nitriles, and to their use as herbicides and pesticides.
Abstract:
A process comprising the reaction of an optionally substituted benzene with thiophosgene in the presence of a Friedel-Crafts catalyst for the preparation of the equivalent optionally substituted benzophenthione and benzophenthiones of formula (I), in which X is H, halogen, alkyl, alkoxy, CN, or dialkylamino. The benzophenthiones are converted into the equivalent benzophenone derivatives by hydrolysis or by oxidation.
Abstract:
Disclosed herein are embodiments of a bi-functionalized dicyclopentadiene monomer and polymer embodiments formed therefrom. The monomer embodiments exhibit tunability and can be used to form thermally stable homopolymers, copolymers, and/or crosslinked polymers.
Abstract:
An object of the present invention is to provide a new method for producing an ALPHA-ketoaldehyde compound from a 2-oxo-primary alcohol compound. The present invention provides a method for producing an ALPHA-ketoaldehyde compound including a step of oxidizing a 2-oxo-primary alcohol compound in the presence of platinum, a platinum compound, iron or an iron compound. The 2-oxo-primary alcohol compound is preferably a compound represented by the formula (1a), and the ALPHA-ketoaldehyde compound is preferably a compound represented by the formula (2a), wherein Ra is a C1-C6 alkyl group which may have a substituent or a C6-C20 aryl group which may have a substituent.